Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02646358
What this trial is testing

Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

Who this might be right for
Pharmacokinetics of VepoloxamerHealthy VolunteersRenal Impaired
Mast Therapeutics, Inc. 27
Early research (Phase 1)Study completedNCT03680352
What this trial is testing

Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects

Who this might be right for
PK in Patients With Various Degrees of Renal Impairment
Allecra 30
Testing effectiveness (Phase 2)Study completedNCT01356849
What this trial is testing

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 149
Early research (Phase 1)Study completedNCT02959138
What this trial is testing

Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function

Who this might be right for
Inflammatory Disease
Gilead Sciences 36
Not applicableStudy completedNCT03536663
What this trial is testing

Clinical Study to Assess the Performance of the Dialyzer With Endexo™

Who this might be right for
Kidney Failure, Chronic
Fresenius Medical Care North America 23
Early research (Phase 1)Study completedNCT02011490
What this trial is testing

Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105)

Who this might be right for
Renal InsufficiencyRenal Impairment
Merck Sharp & Dohme LLC 33
Not applicableActive Not RecruitingNCT05198674
What this trial is testing

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Who this might be right for
HypertensionVascular DiseasesCardiovascular Diseases+2 more
Medtronic Vascular 1,899
Not applicableStudy completedNCT01224782
What this trial is testing

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 994
Early research (Phase 1)Study completedNCT02199379
What this trial is testing

A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects

Who this might be right for
Renal ImpairmentDisease Severity
Eisai Inc. 26
Early research (Phase 1)Study completedNCT01708889
What this trial is testing

Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction

Who this might be right for
Chronic Hepatitis B Virus InfectionChronic Hepatitis C Virus Infection
Bristol-Myers Squibb 43
Early research (Phase 1)Study completedNCT03723785
What this trial is testing

A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney Problems

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 58
Early research (Phase 1)Looking for participantsNCT07619820
What this trial is testing

A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)

Who this might be right for
End Stage Kidney Disease (ESKD)
CSL Behring 24
Not applicableWithdrawnNCT01243515
What this trial is testing

Comparison of a Non-Invasive Central Venous Pressure Device and Physical Examination in Patients With Chronic Kidney Disease

Who this might be right for
Central Venous Pressure
Mespere Lifesciences Inc.
Large-scale testing (Phase 3)Ended earlyNCT01814917
What this trial is testing

Long-term Extension Study of MCI-196

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia+1 more
Tanabe Pharma Corporation 6
Testing effectiveness (Phase 2)Study completedNCT01975818
What this trial is testing

Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 201
Early research (Phase 1)Study completedNCT01508806
What this trial is testing

Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 30
Early research (Phase 1)Study completedNCT05916573
What this trial is testing

Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Haisco Pharmaceutical Group Co., Ltd. 32
Early research (Phase 1)Study completedNCT06547502
What this trial is testing

Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment

Who this might be right for
Diabetes
Gan and Lee Pharmaceuticals, USA 16
Early research (Phase 1)Study completedNCT03087942
What this trial is testing

Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects

Who this might be right for
Renal Insufficiency
Novartis Pharmaceuticals 45
Early research (Phase 1)Ended earlyNCT03947814
What this trial is testing

Orally Administered Pimodivir in Adult Participants With Renal Impairment

Who this might be right for
Kidney Failure, Chronic
Janssen-Cilag International NV 29
Next Page